Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GV1001 with Gemcitabine/Capecitabine in Pancreatic Cancer
NCT02854072Phase 3Unknown
- Start
- Nov 2015
- Primary completion
- May 2018
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of tertomotide in pancreatic ductal adenocarcinoma (PDAC). Status: unknown.
02
Drugs
tertomotide
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02854072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02854072.